Richard Koya

Title: Innovations by Richard Koya in T-Cell Receptor Cloning

Introduction

Richard Koya is an accomplished inventor based in Williamsville, NY (US). He has made significant contributions to the field of immunology, particularly in the area of T-cell receptor (TCR) cloning. His innovative work has the potential to enhance therapeutic approaches for cancer treatment.

Latest Patents

Richard Koya holds a patent for "Compositions and methods for rapid cloning of T-cell receptors." This patent encompasses methods, compositions, recombinant DNA molecules, and kits designed for the cloning of T cell receptors. The methods he developed facilitate the construction of TCR expression libraries from biological samples containing antigen-specific T cells, including tumor biopsies. The engineered peripheral T cells exhibit potent therapeutic anti-tumor effects, showcasing the practical applications of his invention.

Career Highlights

Koya is associated with Health Research, Inc., where he continues to advance his research in T-cell receptor technology. His work is pivotal in developing methods that can be performed using any sample containing T cells, including oligoclonal populations that have infiltrated tumors. His innovative approach includes providing primer combinations for cDNA synthesis and cloning distinct TCR β and TCR α chains into various vectors.

Collaborations

Richard Koya has collaborated with notable colleagues such as Kunle Odunsi and Takemasa Tsuji. These collaborations have further enriched his research and contributed to the advancements in T-cell receptor cloning.

Conclusion

Richard Koya's contributions to T-cell receptor cloning represent a significant advancement in cancer immunotherapy. His innovative methods and compositions have the potential to transform therapeutic strategies in oncology.